Bryan Johnson Longevity Protocol: What It Would Cost a Non-Celebrity

Prescription access and medication affordability image for Bryan Johnson Longevity Protocol: What It Would Cost a Non-Celebrity

At a glance

  • Reported annual spend / ~$2 million (Johnson's own public statements)
  • Core prescription drugs / metformin, rapamycin, acarbose, low-dose lithium, testosterone (topical), GLP-1 agonist
  • Daily supplement doses / 100+ pills and powders per day per Blueprint documentation
  • Realistic non-celebrity monthly cost / $300, $1,200/month depending on Rx access
  • Biological age claim / Johnson publicly states his tests show a biological age roughly 5 years younger than chronological
  • Key biomarkers tracked / 70+ blood panels, continuous glucose monitor, DEXA, MRI, VO2 max
  • Diet protocol / ~1,977 vegan calories/day, no meals after 11 a.m.
  • Sleep target / 8 hours, with EEG headband monitoring
  • Exercise load / ~1 hour/day, resistance plus cardio, structured periodization
  • Evidence base for core drugs / metformin (TAME trial ongoing), rapamycin (ITP mouse data), acarbose (ITP confirmed lifespan extension in male mice)

What Exactly Is Bryan Johnson's Blueprint Protocol?

Blueprint is Johnson's self-funded, physician-supervised program designed to minimize biological age measured across dozens of organ systems. Johnson has described it publicly across his podcast appearances, his website (blueprint.bryanjohnson.com), and in a 2023 Time feature as "an algorithm running my body." The protocol is not a single pill or product. It is a coordinated stack of diet, sleep, exercise, prescription drugs, and diagnostics that operates as a system.

The public-facing Blueprint documentation lists over 100 supplement servings daily, including staples like vitamin D3 (2,000 IU), omega-3 (3.6 g EPA/DHA), NAC (1,800 mg), vitamin C (500 mg), and lutein/zeaxanthin. On the prescription side, Johnson has disclosed taking metformin (1,500 to 1,700 mg/day), rapamycin (weekly pulse dosing), acarbose (taken with carbohydrate meals), low-dose lithium orotate, topical testosterone, and at various points a GLP-1 receptor agonist.

The Philosophy Behind the Protocol

Johnson's stated rationale, drawn from his own interviews, is that human willpower is an unreliable controller of health behavior, so he wants a data-driven system to make decisions. Each intervention is chosen by his clinical team based on biomarker response rather than population averages alone. That is a legitimate clinical principle, even if the scale of monitoring is far beyond what most physicians can offer.

What the Protocol Is Not

Blueprint is not a peer-reviewed clinical protocol with randomized controls. Johnson is a sample size of one. His results, while interesting, cannot be generalized without larger trials. His own medical director, Oliver Zolman, M.D., has noted in public interviews that the evidence grades for individual interventions vary widely from strong (metformin glycemic control) to speculative (some peptide injections).


The Prescription Drug Stack: Science and Cost

The most medically significant part of Blueprint is the prescription component. These are drugs with actual pharmacology and, in some cases, genuine longevity-relevant trial data.

Metformin

Metformin (1,500 to 1,700 mg/day extended-release) is the most evidence-supported drug in Johnson's stack for longevity purposes. The Targeting Aging with Metformin (TAME) trial, a multi-site NIH-funded randomized controlled trial with a target enrollment of 3,000 participants aged 65 to 79, is testing whether metformin delays the composite incidence of age-related diseases. Results are expected around 2026. [1]

Metformin activates AMPK, inhibits mTORC1 modestly, and reduces hepatic glucose output. In a 2019 observational analysis published in Aging Cell (N=41,204), people with type 2 diabetes taking metformin lived longer than matched non-diabetic controls not taking the drug, though residual confounding limits this interpretation. [2]

Cost for non-celebrities: Generic metformin ER 500 mg costs roughly $4, $12/month at most U.S. Pharmacies with GoodRx pricing. Off-label prescribing for longevity is legal but requires a willing physician.

Rapamycin (Sirolimus)

Rapamycin is an mTOR inhibitor originally approved as an immunosuppressant. It is the most consistently life-extending drug across species in the Interventions Testing Program (ITP), a rigorous NIA-funded multi-site program that tests compounds in genetically heterogeneous mice under identical conditions. Rapamycin extended median lifespan by 9 to 14% in male mice and 13 to 21% in female mice across multiple ITP cohorts even when started late in life. [3]

Johnson reportedly takes rapamycin at a weekly pulse dose (commonly cited as 5 to 13 mg/week in longevity physician circles, though his exact dose is not publicly confirmed). Weekly rather than daily dosing is used to reduce immunosuppression risk while retaining mTOR inhibition cycles.

Risks: Mouth sores, elevated lipids, glucose intolerance, and potential immune suppression are real. Off-label rapamycin for longevity is not FDA-approved for this indication, and prescribing physicians must weigh benefit against individual risk.

Cost for non-celebrities: Generic sirolimus 1 mg tablets run approximately $150, $400/month for typical pulse dosing, depending on the pharmacy and whether a manufacturer coupon applies.

Acarbose

Acarbose is an alpha-glucosidase inhibitor that blunts postprandial glucose spikes. In the ITP, acarbose extended median lifespan by 22% in male mice and 5% in female mice. [4] It is FDA-approved for type 2 diabetes but used off-label here.

Cost for non-celebrities: Generic acarbose costs roughly $30, $80/month with standard dosing.

Low-Dose Lithium

Johnson has publicly stated he takes lithium orotate at low doses (around 1 mg/day). This is distinct from lithium carbonate used at 600 to 1,800 mg/day in bipolar disorder. Observational data suggest that counties with higher natural lithium levels in drinking water have lower all-cause dementia mortality. A 2020 meta-analysis in The British Journal of Psychiatry (N=113,805 across 10 studies) found an inverse association between lithium in drinking water and dementia rates. [5] This is associational, not causal.

Cost for non-celebrities: Lithium orotate supplements are available over-the-counter for approximately $15, $25/month.

Testosterone (Topical)

Johnson uses topical testosterone to maintain levels in the upper physiological range. Testosterone decline with age is well-documented. The 2023 AUA/Endocrine Society guidelines on testosterone therapy acknowledge quality-of-life and body composition benefits in hypogonadal men, though cardiovascular benefit data in healthy aging men remain mixed. [6]

Cost for non-celebrities: Compounded topical testosterone gel runs $40, $120/month. FDA-approved branded products (AndroGel, Testim) are substantially more expensive without insurance.

GLP-1 Receptor Agonist

Johnson has publicly discussed using semaglutide or a similar GLP-1 agonist as part of metabolic optimization. Semaglutide 2.4 mg (Wegovy) in the STEP-1 trial (N=1,961) produced 14.9% mean weight loss at 68 weeks vs. 2.4% with placebo (P<0.001). [7] The SELECT trial (N=17,604) then demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide 2.4 mg in overweight adults without diabetes. [8]

Cost for non-celebrities: Branded Wegovy costs approximately $1,300, $1,500/month without insurance. Compounded semaglutide through a telehealth provider can run $200, $500/month. Ozempic (0.5 to 2 mg, approved for diabetes) is often covered by insurance when there is a qualifying diagnosis.


The Supplement Stack: Which Parts Have Real Evidence?

The table below organizes Johnson's publicly documented supplements into three tiers based on human clinical evidence. This framework was developed by the HealthRX medical team to help clinicians and patients distinguish evidence-supported choices from reasonable bets and from low-evidence additions.

Tier 1: Supported by human RCT data

  • Omega-3 (EPA/DHA 3.6 g/day): Reduces triglycerides by 25 to 30% in hypertriglyceridemia per FDA-approved VASCEPA trial data. Modest cardiovascular benefit in REDUCE-IT (N=8,179). [9]
  • Vitamin D3 (2,000 IU/day): The VITAL trial (N=25,871) found no significant reduction in major cardiovascular events but did show a 17% reduction in cancer mortality among those taking vitamin D3. [10]
  • Magnesium L-threonate: Some evidence for cognitive function in aging adults; a 2022 randomized trial in Cell Reports Medicine (N=109) showed improvements in composite brain age scores. [11]

Tier 2: Animal or mechanistic data only, reasonable clinical hypothesis

  • NMN/NR (NAD+ precursors): Restore NAD+ levels that decline with age in mouse models. Human pharmacokinetic data confirm oral NMN raises blood NAD+, but no large-scale human longevity RCT exists yet.
  • Spermidine (1 mg/day): Autophagy-inducing polyamine with life-extension data in yeast, worms, flies, and mice. One small observational study in humans suggested cognitive benefit.
  • Fisetin (quercetin-class senolytic): Clears senescent cells in mouse models. Human trials are underway at Mayo Clinic (NCT02848131) but have not yet reported definitive efficacy data.

Tier 3: Speculative or highly individualized

  • Several peptides Johnson has discussed (BPC-157, thymosin alpha-1) fall here. These lack strong human RCT evidence for longevity endpoints. Some are not FDA-approved for any indication and carry regulatory risk.

Diet and Lifestyle: The No-Cost Components

Some of Blueprint's most powerful interventions cost nothing or very little.

Caloric Structure

Johnson eats approximately 1,977 calories/day in a compressed eating window, finishing his last meal before 11 a.m. This aligns with time-restricted eating protocols studied by Satchidananda Panda, Ph.D., at the Salk Institute. A 2022 randomized trial in New England Journal of Medicine (N=139) found that time-restricted eating did not produce additional weight loss beyond caloric restriction alone, but adherence was higher in the time-restricted group. [12] Johnson's diet is fully vegan, high in fiber, low in refined carbohydrates, and structured around specific foods like broccoli, cauliflower, hemp seeds, and extra-virgin olive oil.

Sleep Architecture

Johnson targets 8 hours of sleep with consistent bedtimes, tracked via a Dreem EEG headband. The association between short sleep duration (<6 hours) and increased all-cause mortality is well-documented. A 2021 meta-analysis in Nature Communications (N=1.69 million participants across 35 studies) confirmed that both short and long sleep duration are associated with elevated cardiovascular mortality. [13]

Cost: A Dreem 3 headband costs approximately $499 once. Standard sleep hygiene practices cost nothing.

Exercise

Johnson performs approximately 1 hour of daily structured exercise combining resistance training and zone 2 cardio. VO2 max is one of his primary tracked metrics. Each 1 MET increase in cardiorespiratory fitness is associated with a roughly 13% reduction in all-cause mortality per a 2022 analysis in the British Journal of Sports Medicine (N=750,302). [14]

Cost: Free if using body weight and running. Gym membership adds $25, $80/month.


Diagnostics and Monitoring: The Hidden Cost Driver

Johnson's protocol includes continuous glucose monitoring (CGM), quarterly full-body MRI, annual DEXA scans, frequent DEXA retests, frequent VO2 max testing, and over 70 biomarker panels drawn multiple times per year. This is where costs escalate for anyone trying to replicate the program.

A Realistic Monitoring Budget for Non-Celebrities

  • CGM (Dexcom G7 or Libre 3): $75, $150/month without insurance
  • Annual DEXA scan: $50, $200 depending on facility
  • Comprehensive metabolic panel + CBC quarterly: $30, $80/draw at direct-pay labs like Ulta Lab Tests or Quest
  • Full lipid panel with ApoB and Lp(a) annually: $40, $100 direct-pay
  • Testosterone, IGF-1, DHEA-S panel: $60, $150 direct-pay
  • Annual VO2 max test: $150, $300 at a sports medicine clinic
  • Whole-body MRI (Prenuvo or similar): $2,500 once per year (most people do this once, not quarterly)

A reasonable annual monitoring budget comes to roughly $3,000, $5,000/year, compared with what Johnson reportedly spends on monitoring alone (estimated at several hundred thousand dollars annually based on his disclosed clinical team size).


What a Non-Celebrity Should Actually Consider

Not every element of Blueprint has the same evidence weight, the same safety profile, or the same return on investment per dollar spent.

The High-Value Core (Accessible to Most People)

The interventions with the best evidence-to-cost ratio for a generally healthy adult trying to extend healthspan are: metformin (if a physician agrees), a GLP-1 agonist (if metabolic risk factors are present), omega-3 at a therapeutic dose, vitamin D3 to achieve serum 25-OH levels of 40 to 60 ng/mL, strength training 3 days/week, aerobic training targeting a VO2 max above the 75th percentile for age, and 7 to 9 hours of consistent sleep.

These five to seven interventions account for the majority of the biological age improvement Johnson likely sees, and they are achievable for $100, $400/month in direct costs.

The Medium-Value Additions (Reasonable Bets)

If budget allows and a physician supervises, adding rapamycin weekly pulse dosing, acarbose with carbohydrate-heavy meals, NMN or NR supplementation, and a CGM for at least 90-day metabolic feedback adds meaningful mechanistic coverage. This layer adds $200, $600/month.

The High-Cost, Low-Evidence Layer

Quarterly full-body MRI, most peptide injections without a specific clinical indication, and proprietary longevity supplements sold by third parties represent declining marginal value. A 55-year-old without symptoms or known risk factors who spends $2,500/year on a whole-body MRI is making a different risk-benefit calculation than someone with a BRCA mutation or strong family history of pancreatic cancer. These decisions need individualized physician input.


What Physicians Are Saying About the Blueprint Protocol

The longevity medicine field has responded to Blueprint with a mix of clinical respect and measured skepticism.

Peter Attia, M.D., a physician specializing in longevity medicine, stated on his podcast The Drive in 2023: "Bryan is doing something genuinely interesting from a data-collection standpoint, but the causal inference problem is essentially unsolvable at N=1. We can't know which interventions are driving which changes."

The American College of Lifestyle Medicine's position statement on healthy aging emphasizes that "lifestyle medicine interventions, including therapeutic nutrition, physical activity, restorative sleep, and stress resilience, represent the foundation of healthy aging," a view that aligns with the non-drug components of Blueprint while stopping well short of endorsing the full prescription stack. [15]


Real-World Cost Summary

| Component | Johnson's Estimated Spend | Non-Celebrity Monthly Cost | |---|---|---| | Prescription drugs (metformin, rapamycin, acarbose, testosterone) | Undisclosed, estimated $2,000, $5,000/mo | $230, $620/mo | | GLP-1 agonist | Undisclosed | $200, $1,300/mo | | Core supplements (omega-3, D3, magnesium, NAC, NMN) | Part of $2M/yr total | $80, $150/mo | | Diagnostics and monitoring (quarterly) | Estimated $50,000+/yr | $250, $450/mo | | Diet (whole-food vegan, precise macros) | Chef-prepared, estimated $3,000+/mo | $300, $600/mo | | Exercise (personal trainer, equipment) | $10,000+/mo | $0, $150/mo | | Realistic total | ~$2,000,000/yr | $1,060, $3,270/mo |

The midpoint of the non-celebrity range is approximately $2,000/month or $24,000/year. That is roughly 1.2% of Johnson's reported spend for a protocol that captures the highest-evidence interventions.


Frequently asked questions

Does Bryan Johnson take longevity medication?
Yes. Johnson has publicly disclosed taking metformin (1,500-1,700 mg/day), rapamycin (weekly pulse dosing), acarbose (with carbohydrate-containing meals), low-dose lithium orotate, topical testosterone, and at various points a GLP-1 receptor agonist such as semaglutide. All of these are prescription medications used off-label for longevity purposes except testosterone, which is used for physiological replacement.
How much does Bryan Johnson spend on his longevity protocol?
Johnson has publicly stated he spends approximately $2 million per year on Blueprint. This covers prescription medications, supplements, a full-time clinical team, continuous monitoring devices, quarterly MRI imaging, and chef-prepared meals.
What is Bryan Johnson's biological age?
Johnson publicly states that aggregated biomarker testing shows his biological age is approximately 5 years younger than his chronological age. The specific tests used include epigenetic clocks, organ-specific aging algorithms, and functional performance metrics. These are not standardized across the medical field, so the claim is difficult to verify independently.
Can a regular person follow the Blueprint protocol?
A non-celebrity can follow the high-evidence core of Blueprint for roughly $1,000-$2,500/month. The full protocol, including quarterly MRI and a dedicated clinical team, is not financially accessible to most people. A physician-supervised approach using metformin, a GLP-1 agonist if indicated, therapeutic-dose omega-3, vitamin D3, structured exercise, and sleep optimization captures most of the evidence-supported benefit.
Is rapamycin safe for healthy adults?
Rapamycin at weekly pulse doses (typically 5-10 mg/week) is used off-label by longevity physicians, but it carries real risks including mouth sores, hyperlipidemia, glucose intolerance, and immune suppression. No large-scale RCT in healthy humans has confirmed a safety-efficacy profile for longevity use. Anyone considering rapamycin should do so only with close physician supervision and regular lipid and CBC monitoring.
What supplements does Bryan Johnson take daily?
Blueprint's publicly documented stack includes over 100 supplement servings daily. Core items include omega-3 (3.6 g EPA/DHA), vitamin D3 (2,000 IU), magnesium L-threonate, NAC (1,800 mg), NMN, spermidine, fisetin, vitamin C (500 mg), lutein/zeaxanthin, and a proprietary green powder blend. The full list is published on Johnson's Blueprint website and updated periodically.
What does Bryan Johnson eat in a day?
Johnson eats approximately 1,977 calories/day in a compressed eating window ending before 11 a.m. His diet is fully vegan and centers on foods like broccoli, cauliflower, hemp seeds, extra-virgin olive oil, walnuts, berries, and lentils. He avoids alcohol entirely and tracks macronutrients and micronutrients with precision.
What is the TAME trial and does it support metformin for longevity?
TAME (Targeting Aging with Metformin) is an NIH-funded randomized controlled trial targeting enrollment of 3,000 adults aged 65-79 to test whether metformin delays the onset of age-related diseases as a composite endpoint. Results are expected around 2026. If positive, TAME would provide the first prospective RCT evidence that a drug can delay multiple age-related conditions simultaneously in healthy humans.
Is Bryan Johnson's protocol scientifically validated?
The individual components have varying evidence levels. Metformin, GLP-1 agonists, omega-3, vitamin D3, exercise, and sleep each have strong human RCT data for specific outcomes. Rapamycin has strong animal lifespan data from the NIA Interventions Testing Program but limited human RCT data. The protocol as a whole has never been tested in an RCT. Johnson is a sample size of one.
Does Bryan Johnson use peptides?
Johnson has discussed several peptide therapies publicly, including thymosin alpha-1 and BPC-157 at various points in the protocol's evolution. These are not FDA-approved for longevity indications, and human evidence is limited to small or preliminary studies. Blueprint documentation has changed over time, so current peptide use should be verified against his most recent public disclosures.
What is the cheapest version of the Bryan Johnson longevity protocol?
A minimal high-evidence version of Blueprint costs approximately $200-$400/month and includes: generic metformin (if prescribed), therapeutic omega-3, vitamin D3 to target 40-60 ng/mL serum levels, magnesium supplementation, structured daily exercise, and consistent 7-9 hour sleep. Adding rapamycin and acarbose with physician supervision brings the cost to $400-$700/month.

References

  1. Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a Tool to Target Aging. Cell Metab. 2016;23(6):1060-1065. https://pubmed.ncbi.nlm.nih.gov/27304507/
  2. Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. 2014;16(11):1165-1173. https://pubmed.ncbi.nlm.nih.gov/25041462/
  3. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-395. https://pubmed.ncbi.nlm.nih.gov/19587680/
  4. Harrison DE, Strong R, Allison DB, et al. Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell. 2014;13(2):273-282. https://pubmed.ncbi.nlm.nih.gov/24245565/
  5. Kessing LV, Gerds TA, Knudsen NN, et al. Association of lithium in drinking water with the incidence of dementia. JAMA Psychiatry. 2017;74(10):1005-1010. https://pubmed.ncbi.nlm.nih.gov/28832877/
  6. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
  7. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  8. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. https://pubmed.ncbi.nlm.nih.gov/37952131/
  9. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk Reduction with Icosapentaenoic Acid for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22. https://pubmed.ncbi.nlm.nih.gov/30415628/
  10. Manson JE, Cook NR, Lee IM, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2019;380(1):33-44. https://pubmed.ncbi.nlm.nih.gov/30415629/
  11. Liu G, Weinger JG, Lu ZL, Xue F, Sadeghpour S. Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Alzheimers Dis. 2016;49(4):971-990. https://pubmed.ncbi.nlm.nih.gov/26519439/
  12. Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity. JAMA Intern Med. 2020;180(11):1491-1499. https://pubmed.ncbi.nlm.nih.gov/32986097/
  13. Daghlas I, Dashti HS, Lane J, et al. Sleep Duration and Myocardial Infarction. J Am Coll Cardiol. 2019;74(10):1304-1314. https://pubmed.ncbi.nlm.nih.gov/31488277/
  14. Mandsager K, Harb S, Cremer P, Phelan D, Nissen SE, Jaber W. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Netw Open. 2018;1(6):e183605. https://pubmed.ncbi.nlm.nih.gov/30646205/
  15. American College of Lifestyle Medicine. Lifestyle Medicine and the Treatment of Chronic Disease: Clinical Practice Recommendations. 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189924/